| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K19103580 |
| PharmacoGx | BRD-K19103580 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XCL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | SLC13A3 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | IMPG1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ASCL4 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | PKD1L3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | ABC13-47656900H15.1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | GPR101 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | ACTG2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | KIR3DL3 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
